CLINICAL TRIALS PROFILE FOR DILTIAZEM HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for DILTIAZEM HYDROCHLORIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00000478 ↗ | Asymptomatic Cardiac Ischemia Pilot (ACIP) Study | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1990-11-01 | To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia. |
| NCT00000556 ↗ | Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) | Completed | National Heart, Lung, and Blood Institute (NHLBI) | Phase 3 | 1995-03-01 | To compare two standard treatment strategies for atrial fibrillation: ventricular rate control and anticoagulation vs. rhythm control and anticoagulation. |
| NCT00007592 ↗ | Hypertension Screening and Treatment Program | Completed | US Department of Veterans Affairs | 1989-06-01 | Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension. | |
| NCT00007592 ↗ | Hypertension Screening and Treatment Program | Completed | VA Office of Research and Development | 1989-06-01 | Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension. | |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for DILTIAZEM HYDROCHLORIDE
Condition Name
Clinical Trial Locations for DILTIAZEM HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for DILTIAZEM HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for DILTIAZEM HYDROCHLORIDE
Sponsor Name
